Key technologies in Alzheimer's Disease clinical trials 2021

Published by
Matej Mikulic,
Nov 23, 2022
As of early 2021, 22 clinical trials for Alzheimer's disease used the β-amyloid mAb technology for a monoclonal antibody treatment. This statistic depicts the number of clinical trials for Alzheimer’s Disease products in the global pipeline as of 2021, by key technology.

Number of clinical trials for Alzheimer’s Disease products worldwide as of 2021, by key technology

Loading statistic...

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

February 2021

Region

Worldwide

Survey time period

as of February 2021

Number of respondents

109*

Supplementary notes

* Technologies with at least 2 clinical trials ongoing.
** Other includes various technologies each with <4 clinical trials, including: APP inhibitor, TKIs, Omega-3 fatty acid, NMDA receptor antagonist, α-2 adrenergic receptor agonist, AAV gene therapy, Nicotinamide riboside, 18-kDa TSPO radioligand, AChE inhibitor, QC inhibitor, Interleukin inhibitors, HGF stimulants, and undefined.

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Register now
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Clinical trials "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Clinical trials

R&D overview

6

Top R&D companies

5

Clinical studies

7

Participation

4

Costs and market

6

Approvals, launches, setbacks

6

COVID-19

4

Further related statistics

9

Further Content: You might find this interesting as well

Statistics

Topics

Pharmaceutical market in ThailandDemographics of ThailandHealth in ThailandMedical device industry in ThailandCoronavirus (COVID-19) pandemic in Thailand
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Register now
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.
Menu